Charles S. Berkman - 10 Jun 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
Charles S. Berkman
Issuer symbol
LGND
Transactions as of
10 Jun 2022
Transactions value $
$0
Form type
4
Date filed
14 Jun 2022, 17:55
Previous filing
09 May 2022
Next filing
30 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Award $0 +5.38K +17.68% $0.00 35.8K 10 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.